Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial
- Resource Type
- Article
- Source
- In
Vaccine 1 May 2014 32(21):2507-2517 - Subject
- Language
- ISSN
- 0264-410X